Replies to post #119575 on Amarantus Bioscience Holdings Inc (AMBS)

[GoClippers]

Let me preface a response to your question with the following assumption - that you don't think GC is a liar. If you do, there is no response. If you don't, here goes.

From his blog:

"Diagnostics Transaction

Last week, the Company’s diagnostics team made good progress on the commercial launch plan for MSPrecise® at a meeting we held in Dallas, TX. We are also continuing to evaluate the next set of studies to further enhance LymPro’s value by combining datasets with other markers, such as PET imaging. We have come to the decision that we will be focusing on the assets currently in the company, and will forego the option agreement with Georgetown University. With data coming up on the use of LymPro in Chronic Traumatic Encephalopathy that we recently completely enrollment for in Boston University’s DETECT study, we believe we have sufficient critical mass to make a very successful business from our current diagnostics portfolio and are now focused on the CLIA launch plans for these products. We remain on track to transact on the diagnostics division in the fourth quarter and will provide updates on this as progress is made. The Company is looking forward to the JP Morgan Healthcare Conference the week of January 11, 2016 as a key time to potentially make public announcements of definitive agreements."

It's coming. This quarter.

We may be disappointed by the transaction. But he addressed it in his blog. I think they have a deal in place contingent on CLIA approvals on both MsPrecise and Lympro. (Just speculation on my part.)

what's disconcerting about the Intl. Infusion post is that Jeff Stevens mentioned some wonderful aspects of the company and its pipe. But the reality is thus far, they've been unable to obtain clean and sufficient funding or BP Partnerships with cash in hand. They've had miles upon miles of runway and time to do so, yet they've failed miserably at it.

Why? Thats the question that they've failed to address with their shareholders. Gerald has completely avoided discussing it in his last Blog.

Gerald, how can you "trust the science" when there is no legitmate financing that you've been able to provide to carry the pipe?

What am I missing here ???